Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response.
Main Authors: | Milena Z. Adzemovic, Manuel Zeitelhofer, Ulf Eriksson, Tomas Olsson, Ingrid Nilsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3735721 |
Similar Items
-
Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.
by: Milena V Adzemovic, et al.
Published: (2013-01-01) -
Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response
by: Milena Z. Adzemovic, et al.
Published: (2013-01-01) -
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
by: Manuel Zeitelhofer, et al.
Published: (2020-12-01) -
Correction: imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.
by: PLOS ONE Staff
Published: (2015-01-01) -
Expression of Ccl11 associates with immune response modulation and protection against neuroinflammation in rats.
by: Milena Z Adzemovic, et al.
Published: (2012-01-01)